ALSO NOTED: FDA requires electronic drug labeling; Niccotine vaccine on the horizon; Cancer drug could fight scleroderma; and m

> The FDA said Wednesday that drug makers must begin submitting electronic versions of their drug labels to build a database that doctors and patients can search for recent warnings or other changes. Release

> Researchers presenting at the American Association for Cancer Research meeting in Baltimore on Wednesday reported strong safety and efficacy results for NicVAX, a vaccine that could help millions of smokers quit. There are several nicotine vaccines in development, but NicVax, which is closing in on phase 3 trial, will likely make it to the FDA first. Report

> Duke University Medical Center researchers have found that the anti cancer-drug paclitaxel (Taxol) may also prevent skin thickening and small blood vessel destruction in people with scleroderma. Report

> King Pharmaceuticals will pay $124 million plus interest to settle allegations of Medicaid fraud. Report

> GSK has opened a new $3 million facility in Cape Town, South Africa, to produce its de-worming agent albendazole. Release

And Finally... The identity of Jack the Ripper may soon be revealed by DNA technology developed in Australia. Report